Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Jean-Michel CayuelaLaboratory of Haematology, Saint-Louis University Hospital, Assistance Publique - Hôpitaux de Paris, UA3518 Univeristé Paris Cité Paris France.ORCID 0000-0002-6039-4270
Pierre SujobertHospices Civils de Lyon, Service d'Hématologie Biologique Lyon France.ORCID 0000-0002-9108-1162
Pascale Flandrin-GrestaLaboratoire d'Hématologie, Hôpital NORD University Hospital Saint-Etienne Saint Etienne France.
Anne-Sophie AlaryLaboratoire d'Oncogénétique, Institut Paoli Calmettes Marseille France.
Carole MautePlateforme du GBMHM, Laboratoire d'Hématologie, Hôpital St Louis Paris France.
Damien Luque-PazCRCI2NA, INSERM, Centre Hospitalier Universitaire de Angers University of Angers, University of Rennes 1, Université Angers UFR Sciences Angers France.ORCID 0000-0002-4523-675X
Cédric PastoretLaboratory of Hematology, Rennes University Hospital Rennes France.
Stéphanie DulucqLaboratory of Hematology, University Hospital of Bordeaux, INSERM, BRIC Bordeaux France.
Audrey GauthierPlateforme du GBMHM, Laboratoire d'Hématologie, Hôpital St Louis Paris France.
Meryl DarlingtonDRCI-URC Eco Ile-de-France, Assistance Publique-Hôpitaux de Paris (AP-HP) Paris France.
Olivier KosmiderService d'Hématologie Biologique, GH AP-HP Centre, INSERM U1016 Institut Cochin - Université Paris Cité Paris France.
Elizabeth MacintyreUniversité Paris Cité, INSERM UMR1151 and Onco-Hematology Laboratory, Necker-Enfants Malades Hospital, Assistance-Publique Hôpitaux de Paris Paris France.ORCID 0000-0003-0520-0493
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Implementation science in hemato-oncology molecular diagnostics in France via the Groupe des Biologistes Moléculaire des Hémopathies Malignes (GBMHM). · full record | OpenQuestion